![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Diethyldioxystilbene Diphosphate
2. Diethylstilbestrol Diphosphate
3. Difostilben
4. Fosfesterol
5. Fosfestrol, (e)-isomer
6. Fosfestrol, 99tc-labeled Cpd
7. Fosfestrol, Disodium Salt, (e)-isomer
8. Fosfestrol, Sodium Salt, (e)-isomer
9. Fosfestrol, Tetrasodium Salt, (e)-isomer
10. Fostestrolum
11. Fostrolin
12. Honvan
13. Kyorin
14. St-52
15. Stilbestrol Diphosphate
16. Stilphostrol
1. Diethylstilbestrol Diphosphate
2. 522-40-7
3. Phosphestrol
4. Honvan
5. Stilbestrol Diphosphate
6. Phosphoestrolum
7. (e)-hex-3-ene-3,4-diylbis(4,1-phenylene) Bis(dihydrogen Phosphate)
8. Fosfestrol [inn]
9. A0e0nma80f
10. [4-[(e)-4-(4-phosphonooxyphenyl)hex-3-en-3-yl]phenyl] Dihydrogen Phosphate
11. Chebi:4532
12. Diethylstilbestrol Diphosphate [usp]
13. Ncgc00181335-01
14. Desdp
15. St52-asta
16. Stilphostrol (tn)
17. Diethylstilbestryl Diphosphate
18. Diethylstilbesterol Diphosphate
19. Fosfestrolum
20. Diethylstilbestrol Diphosphate (usp)
21. Fosfestrolum [inn-latin]
22. Ccris 2778
23. Einecs 208-328-8
24. Unii-a0e0nma80f
25. Phenol, 4,4'-((1e)-1,2-diethyl-1,2-ethenediyl)bis-, Bis(dihydrogen Phosphate)
26. Phenol, 4,4'-[(1e)-1,2-diethyl-1,2-ethenediyl]bis-, Bis(dihydrogen Phosphate)
27. 13425-53-1
28. Fosfestrol [mi]
29. Fosfestrol (jan/inn)
30. Fosfestrol [jan]
31. Alpha,alpha'-diethyl-(e)-4,4'-stilbenediol Bis(dihydrogen Phosphate)
32. Fosfestrol [mart.]
33. Schembl9370
34. Dsstox_cid_26906
35. Dsstox_rid_82005
36. Fosfestrol [who-dd]
37. Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, Bis(dihydrogen Phosphate), (e)-
38. Dsstox_gsid_46906
39. Diethylstilbestrol Bisphosphate
40. Chembl1200598
41. Dtxsid3046906
42. (e)-4,4'-(hex-3-ene-3,4-diyl)bis(4,1-phenylene) Bis(dihydrogen Phosphate)
43. 3-hexene-3,4-diylbis(4,1-phenylene) Bis[dihydrogen (phosphate)]
44. Zinc1531012
45. Tox21_112794
46. 4,4'-stilbenediol, Alpha,alpha'-diethyl-, Bis(dihydrogen Phosphate), (e)-
47. Akos005267157
48. Cas-522-40-7
49. 3,4-bis[p-(phosphonooxy)phenyl]-3-hexene
50. Bb 0266147
51. Diethylstilbestrol Diphosphate [vandf]
52. C08145
53. D00946
54. Sr-01000945066
55. Diethylstilbestrol Diphosphate [orange Book]
56. Q1003185
57. Sr-01000945066-1
58. .alpha.,.alpha.'-diethyl-(e)-4,4'-stilbenediol Bis(dihydrogen Phosphate)
59. [4-[(e)-1-ethyl-2-(4-phosphonooxyphenyl)but-1-enyl]phenyl] Dihydrogen Phosphate
60. 4-{1-ethyl-2-[4-(phosphonooxy)phenyl]-1-butenyl}phenyl Dihydrogen Phosphate
61. Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, Bis(dihydrogen Phosphate), (e)
Molecular Weight | 428.3 g/mol |
---|---|
Molecular Formula | C18H22O8P2 |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 8 |
Exact Mass | 428.07899165 g/mol |
Monoisotopic Mass | 428.07899165 g/mol |
Topological Polar Surface Area | 134 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 568 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
L - Antineoplastic and immunomodulating agents
L02 - Endocrine therapy
L02A - Hormones and related agents
L02AA - Estrogens
L02AA04 - Fosfestrol